Korea's Seegene unveils Open Innovation Programme in partnership with Springer Nature

Seegene Inc., a leading South Korean company providing a total solution for polymerase chain reaction (PCR) molecular di...

September 5, 2023 | Tuesday | News
Yourgene Health launches MagBench automated DNA extraction instrument and kit for NIPT workflows

UK-headquartered Yourgene Health plc, a leading international molecular diagnostics group, has launched the Yourgene&nbs...

September 6, 2023 | Wednesday | News
How blood-based protein biomarkers enable early detection and intervention of Alzheimer’s disease

Alzheimer's disease (AD) is a rapidly growing global public health concern, with an estimated 55 million patients worldw...

September 1, 2023 | Friday | Opinion
Singapore's INEX Innovate launches epiHERA® to detect Early Endometrial Cancer

INEX Innovate, Singapore’s pioneering Women’s Life Science Health Innovations group, has launched epiHERA&re...

August 29, 2023 | Tuesday | Company results
China-based MGI partners with Korean startup NGeneBio to advance precision medicine

MGI, a China-based company committed to building core tools and technology to lead life scienc,e and South Korea based s...

August 23, 2023 | Wednesday | News
Mirxes inks new deals to scale adoption of early cancer detection solutions in APAC

Mirxes, a Singapore headquartered RNA technology company that is making diagnostic solutions for the early detection of ...

August 22, 2023 | Tuesday | News
Korea designs non-invasive test as breakthrough in early diagnosis of bladder cancer

Bladder cancer has a five-year survival rate of over 80% when detected early, but this rate declines significantly as th...

August 18, 2023 | Friday | News
Mirxes receives US FDA’s Breakthrough Device Designation for blood-based cancer detection test

Mirxes Corporation USA, the wholly owned subsidiary of Mirxes Pte Ltd, a Singapore-headquartered RNA technolog...

August 16, 2023 | Wednesday | News
“Asia-Pacific represents a vast and relatively untapped market for Digital Pathology”

How does your innovative technology differ from traditional pathology methods? JelloX Biotech is revolutionising cancer...

August 2, 2023 | Wednesday | Opinion
Genomic profiling offers hope for 23,000 cancer patients in Australia

A high technology genomic profiling programme supported by the Australian government will examine new treatments for adv...

July 31, 2023 | Monday | News
Korean startup Lunit accelerates expansion across Middle East with new supply contract

Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, con...

July 26, 2023 | Wednesday | News
China-based Fapon announces global launch of Chemiluminescence Immunoassay system Shine i8000/9000

China headquartered life sciences company Fapon has announced the launch of its latest chemiluminescence immunoassa...

July 26, 2023 | Wednesday | News
DuoPharma Biotech to scale screening device iBreastExam across Malaysia

Malaysia’s leading pharmaceutical company Duopharma Biotech has signed a Distribution Agreement to scale iBre...

July 24, 2023 | Monday | News
Japan-based Fujirebio partners with Beckman Coulter to bolster access to blood-based Alzheimer’s Disease test

US-based Beckman Coulter Diagnostics and Fujirebio, a leader in neurological markers and In Vitro Diagnostic (IVD) manuf...

July 18, 2023 | Tuesday | News
Quest Diagnostics with Australian firm Envision Sciences launches novel prostate cancer test in US

US-based Quest Diagnostics has announced the launch of a novel prostate cancer biomarker test through its subspecialty p...

July 18, 2023 | Tuesday | News
Germany-Saudi Arabian tie up of $30 M for data-driven multiomic testing

Germany-based Centogene, the essential life science partner for data-driven answers in rare and neurodegenerative diseas...

July 3, 2023 | Monday | News
Australia explores use of yeast dust to make affordable diagnostic test

Researchers from The University of Queensland (UQ), Australia, have made a dust from baker’s yeast that can detect...

July 3, 2023 | Monday | News
Prenetics launches $200 M JV for multi-cancer early detection in Hong Kong

Prenetics Global, a leading genomics-driven health sciences company in Hong Kong, and Prof. Dennis Lo have entered ...

June 27, 2023 | Tuesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls